Johnson & Johnson (NYSE: JNJ) recently released its Q1 earnings, surpassing analyst estimates on both revenue and earnings. The company posted adjusted earnings of $2.77 per share on revenue of $ ...

Johnson & Johnson is scheduled to announce its earnings on Tuesday, April 15, 2025. Analysts expect earnings of $2.59 per share on revenue of $21.6 billion for the current year, compared to $2.71 ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy ...

Since September 2024, Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19. Does this present a buying opportunity for JNJ? Or is its ...

Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over 5% year-to-date, mainly due to solid financials ...

Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the JNJ ...

One of the best pharma stocks to add to your portfolio is Johnson & Johnson (JNJ), a blue chip healthcare company with a long history of rewarding shareholders. It boasts a strong balance sheet ...